» Articles » PMID: 29973955

Effects of Different Treatment Strategies and Tumor Stage on Survival of Patients with Advanced Laryngeal Carcinoma: A 15-Year Cohort Study

Overview
Publisher Wiley
Specialty Oncology
Date 2018 Jul 6
PMID 29973955
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Laryngeal cancer is the second most common cancer in the head and neck. Since laryngeal cancer management is a complex process, there is still no standard strategy to treat this disease in order to increase the survival rate of the patients especially among those with advanced form of the disease.

Methods: A cohort study was undertaken to analyze factors predicting survival of the patients in advanced stage laryngeal cancer in the Southern Iran among all patients newly diagnosed with laryngeal cancer between 2000 and 2015.

Results: Data of a total number of 415 patients who have had been diagnosed with advanced laryngeal cancer during this period was used for analysis. The patients' 1-, 3-, 5-, and 10-year survival rates were 81%, 62%, 53%, and 38%, respectively. Multivariable Cox regression analyses indicated a significant relationship between patients' survival and age at diagnosis ( < 0.001), disease stage ( = 0.002), tumor grade ( = 0.008), positive L. node ( = 0.008), and type of treatment ( < 0.001). As expected, treatment strategy was identified as the most effective factor in survival of the patients. According to the results, patients who undergone surgical treatment experienced a longer survival than those who received other treatments.

Conclusion: This study showed that the survival of patients depends on several factors, among which, treatment strategy is the most important. Combination of total laryngectomy plus chemoradiation provides superior local control and better survival compared to either radiotherapy or chemoradiation in patients with advanced laryngeal cancer.

Citing Articles

Machine learning in personalized laryngeal cancer management: insights into clinical characteristics, therapeutic options, and survival predictions.

Alshwayyat S, Kamal T, Alshwayyat T, Alshwayyat M, Hanifa H, Odat R Eur Arch Otorhinolaryngol. 2024; 282(2):945-960.

PMID: 39714621 DOI: 10.1007/s00405-024-09171-1.


Chemoradiotherapy vs radiotherapy for non-surgical locally advanced laryngeal squamous cell carcinoma patients: a propensity score-matched study and practical nomogram construction.

Zhang Y, Wang Z, Zheng Y Eur Arch Otorhinolaryngol. 2023; 281(3):1449-1456.

PMID: 38158418 DOI: 10.1007/s00405-023-08360-8.


Survival Outcomes in T3 Laryngeal Cancers: Primary Total Laryngectomy vs. Concurrent Chemoradiation or Radiation Therapy-A Meta-Analysis.

Rao K, Pai P, Dange P, Kowalski L, Strojan P, Makitie A Biomedicines. 2023; 11(8).

PMID: 37626625 PMC: 10452463. DOI: 10.3390/biomedicines11082128.


Outcomes of organ preservation treatment in advanced laryngeal carcinoma: A retrospective analysis from a single institution.

Fasaludeen A, Kumar R, Rafi M, Nazeer F, Prakasan A, Kumar N Mol Clin Oncol. 2022; 18(1):1.

PMID: 36545209 PMC: 9756020. DOI: 10.3892/mco.2022.2597.


Investigation of the affective factors on the survival rate of patients with laryngeal cancer using Cox proportional hazards and Lin -Ying's additive hazards models.

Zarei M, Mirzaee M, Alizadeh H, Jahani Y Med J Islam Repub Iran. 2021; 35:16.

PMID: 33996667 PMC: 8111620. DOI: 10.47176/mjiri.35.16.


References
1.
Dianatinasab M, Ghaem H, Rezaianzadeh A, Hosseini S, Khazraei H . Colorectal Cancer Mortality in Shiraz, Iran. Asian Pac J Cancer Prev. 2016; 17(8):4101-5. View

2.
Zhang S, Lu Z, Luo X, Chen L, Ge P, Song X . Retrospective analysis of prognostic factors in 205 patients with laryngeal squamous cell carcinoma who underwent surgical treatment. PLoS One. 2013; 8(4):e60157. PMC: 3617169. DOI: 10.1371/journal.pone.0060157. View

3.
Roshandel G, Semnani S, Fazel A, Honarvar M, Taziki M, Sedaghat S . Building cancer registries in a lower resource setting: The 10-year experience of Golestan, Northern Iran. Cancer Epidemiol. 2018; 52:128-133. DOI: 10.1016/j.canep.2017.12.014. View

4.
Fararouei M, Marzban M, Shahraki G . Completeness of cancer registry data in a small Iranian province: A capture-recapture approach. Health Inf Manag. 2016; 46(2):96-100. DOI: 10.1177/1833358316668605. View

5.
Dianatinasab M, Fararouei M, Mohammadianpanah M, Zare-Bandamiri M . Impact of social and clinical factors on diagnostic delay of breast cancer: A Cross-sectional Study. Medicine (Baltimore). 2016; 95(38):e4704. PMC: 5044888. DOI: 10.1097/MD.0000000000004704. View